article thumbnail

Angion stock falls after agreeing Elicio Therapeutics merger

pharmaphorum

The AMP technology was developed by the laboratories of Darrell Irvine, professor of biomedical engineering in the Koch Institute of Integrative Cancer Research at MIT, who is a co-founder of Elicio, as well as serving as a consultant to the company and head of its scientific advisory board.

article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

He is now an independent GMC consultant. Patent Protection of Pharmacologically Active Metabolites: Theoretical and Technological Analysis on the Jurisprudence of Four Regions. About the author. Dave Elder has nearly 40 years of service within the pharmaceutical industry at Sterling, Syntext and GlaxoSmithKline. CN202010111235.3A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 5 Best Pharmaceutical Sales Training Programs

MedReps

Consultative Selling. At the heart of any solid pharmaceutical sales training program is consultative selling or the act of solving problems for your customer. As someone new to the industry, a pharmaceutical training program can offer you: A comprehensive base of knowledge in pharmacology and medical terms.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. These issues will be explored in the final article of this series. About the author.

FDA 98
article thumbnail

3D Medical Animation: Transforming Healthcare Communication with Precision and Clarity

Infuse Medical

We create animations that appeal to the target audience from depicting pharmacological processes of action to elucidating complicated medical gadgets. Get in touch with us for a consultation or to request a demo. Since this phase forms the basis of the project as whole, it is vital.

Medical 130
article thumbnail

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Legacy MEDSearch

The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro. Nevro routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.nevro.com. About Nevro.

FDA 52
article thumbnail

Strategies for Streamlining Small Molecule Formulation Development When Bridging from Candidate Selection to First-in-Human Clinical Testing

Pharmaceutical Technology

At Quotient Sciences, our drug development consultants use our 30+ years of experience in clinical research outcomes to profile each new molecule that we look at. It is important to assess each compound’s pharmacokinetic (PK) profile and to evaluate the potential toxicity using simple screens such as the Ames test and cytotoxicity assays.